Global Intramuscular Drug Delivery Market Research Report 2023

Report ID: 1891034 | Published Date: Feb 2026 | No. of Page: 86 | Base Year: 2025 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Intramuscular Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Drug Molecule
        1.2.3 Delivery Devices
    1.3 Market by Application
        1.3.1 Global Intramuscular Drug Delivery Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Infectious Disease
        1.3.3 Oncology
        1.3.4 Autoimmune Diseases
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Intramuscular Drug Delivery Market Perspective (2017-2028)
    2.2 Intramuscular Drug Delivery Growth Trends by Region
        2.2.1 Intramuscular Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Intramuscular Drug Delivery Historic Market Size by Region (2017-2022)
        2.2.3 Intramuscular Drug Delivery Forecasted Market Size by Region (2023-2028)
    2.3 Intramuscular Drug Delivery Market Dynamics
        2.3.1 Intramuscular Drug Delivery Industry Trends
        2.3.2 Intramuscular Drug Delivery Market Drivers
        2.3.3 Intramuscular Drug Delivery Market Challenges
        2.3.4 Intramuscular Drug Delivery Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Intramuscular Drug Delivery Players by Revenue
        3.1.1 Global Top Intramuscular Drug Delivery Players by Revenue (2017-2022)
        3.1.2 Global Intramuscular Drug Delivery Revenue Market Share by Players (2017-2022)
    3.2 Global Intramuscular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Intramuscular Drug Delivery Revenue
    3.4 Global Intramuscular Drug Delivery Market Concentration Ratio
        3.4.1 Global Intramuscular Drug Delivery Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Intramuscular Drug Delivery Revenue in 2021
    3.5 Intramuscular Drug Delivery Key Players Head office and Area Served
    3.6 Key Players Intramuscular Drug Delivery Product Solution and Service
    3.7 Date of Enter into Intramuscular Drug Delivery Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Intramuscular Drug Delivery Breakdown Data by Type
    4.1 Global Intramuscular Drug Delivery Historic Market Size by Type (2017-2022)
    4.2 Global Intramuscular Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Intramuscular Drug Delivery Breakdown Data by Application
    5.1 Global Intramuscular Drug Delivery Historic Market Size by Application (2017-2022)
    5.2 Global Intramuscular Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Intramuscular Drug Delivery Market Size (2017-2028)
    6.2 North America Intramuscular Drug Delivery Market Size by Country (2017-2022)
    6.3 North America Intramuscular Drug Delivery Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Intramuscular Drug Delivery Market Size (2017-2028)
    7.2 Europe Intramuscular Drug Delivery Market Size by Country (2017-2022)
    7.3 Europe Intramuscular Drug Delivery Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Intramuscular Drug Delivery Market Size (2017-2028)
    8.2 Asia-Pacific Intramuscular Drug Delivery Market Size by Country (2017-2022)
    8.3 Asia-Pacific Intramuscular Drug Delivery Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Intramuscular Drug Delivery Market Size (2017-2028)
    9.2 Latin America Intramuscular Drug Delivery Market Size by Country (2017-2022)
    9.3 Latin America Intramuscular Drug Delivery Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Intramuscular Drug Delivery Market Size (2017-2028)
    10.2 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2017-2022)
    10.3 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Antares Pharma
        11.1.1 Antares Pharma Company Detail
        11.1.2 Antares Pharma Business Overview
        11.1.3 Antares Pharma Intramuscular Drug Delivery Introduction
        11.1.4 Antares Pharma Revenue in Intramuscular Drug Delivery Business (2017-2022)
        11.1.5 Antares Pharma Recent Development
    11.2 Eli Lily
        11.2.1 Eli Lily Company Detail
        11.2.2 Eli Lily Business Overview
        11.2.3 Eli Lily Intramuscular Drug Delivery Introduction
        11.2.4 Eli Lily Revenue in Intramuscular Drug Delivery Business (2017-2022)
        11.2.5 Eli Lily Recent Development
    11.3 Galaxo
        11.3.1 Galaxo Company Detail
        11.3.2 Galaxo Business Overview
        11.3.3 Galaxo Intramuscular Drug Delivery Introduction
        11.3.4 Galaxo Revenue in Intramuscular Drug Delivery Business (2017-2022)
        11.3.5 Galaxo Recent Development
    11.4 HMD pharmaceuticals
        11.4.1 HMD pharmaceuticals Company Detail
        11.4.2 HMD pharmaceuticals Business Overview
        11.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Introduction
        11.4.4 HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022)
        11.4.5 HMD pharmaceuticals Recent Development
    11.5 Inovio Pharmaceuticals
        11.5.1 Inovio Pharmaceuticals Company Detail
        11.5.2 Inovio Pharmaceuticals Business Overview
        11.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Introduction
        11.5.4 Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022)
        11.5.5 Inovio Pharmaceuticals Recent Development
    11.6 Merck
        11.6.1 Merck Company Detail
        11.6.2 Merck Business Overview
        11.6.3 Merck Intramuscular Drug Delivery Introduction
        11.6.4 Merck Revenue in Intramuscular Drug Delivery Business (2017-2022)
        11.6.5 Merck Recent Development
    11.7 Novartis
        11.7.1 Novartis Company Detail
        11.7.2 Novartis Business Overview
        11.7.3 Novartis Intramuscular Drug Delivery Introduction
        11.7.4 Novartis Revenue in Intramuscular Drug Delivery Business (2017-2022)
        11.7.5 Novartis Recent Development
    11.8 Pacira Pharmaceuticals
        11.8.1 Pacira Pharmaceuticals Company Detail
        11.8.2 Pacira Pharmaceuticals Business Overview
        11.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Introduction
        11.8.4 Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022)
        11.8.5 Pacira Pharmaceuticals Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Detail
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Intramuscular Drug Delivery Introduction
        11.9.4 Pfizer Revenue in Intramuscular Drug Delivery Business (2017-2022)
        11.9.5 Pfizer Recent Development
    11.10 Pharmajet
        11.10.1 Pharmajet Company Detail
        11.10.2 Pharmajet Business Overview
        11.10.3 Pharmajet Intramuscular Drug Delivery Introduction
        11.10.4 Pharmajet Revenue in Intramuscular Drug Delivery Business (2017-2022)
        11.10.5 Pharmajet Recent Development
    11.11 Teva Pharmaceutical
        11.11.1 Teva Pharmaceutical Company Detail
        11.11.2 Teva Pharmaceutical Business Overview
        11.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Introduction
        11.11.4 Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2017-2022)
        11.11.5 Teva Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Intramuscular Drug Delivery Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Drug Molecule
    Table 3. Key Players of Delivery Devices
    Table 4. Global Intramuscular Drug Delivery Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Intramuscular Drug Delivery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Intramuscular Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Intramuscular Drug Delivery Market Share by Region (2017-2022)
    Table 8. Global Intramuscular Drug Delivery Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Intramuscular Drug Delivery Market Share by Region (2023-2028)
    Table 10. Intramuscular Drug Delivery Market Trends
    Table 11. Intramuscular Drug Delivery Market Drivers
    Table 12. Intramuscular Drug Delivery Market Challenges
    Table 13. Intramuscular Drug Delivery Market Restraints
    Table 14. Global Intramuscular Drug Delivery Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Intramuscular Drug Delivery Market Share by Players (2017-2022)
    Table 16. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Drug Delivery as of 2021)
    Table 17. Ranking of Global Top Intramuscular Drug Delivery Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Intramuscular Drug Delivery Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Intramuscular Drug Delivery Product Solution and Service
    Table 21. Date of Enter into Intramuscular Drug Delivery Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Intramuscular Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Intramuscular Drug Delivery Revenue Market Share by Type (2017-2022)
    Table 25. Global Intramuscular Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Intramuscular Drug Delivery Revenue Market Share by Type (2023-2028)
    Table 27. Global Intramuscular Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Intramuscular Drug Delivery Revenue Market Share by Application (2017-2022)
    Table 29. Global Intramuscular Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Intramuscular Drug Delivery Revenue Market Share by Application (2023-2028)
    Table 31. North America Intramuscular Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Intramuscular Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Intramuscular Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Intramuscular Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Intramuscular Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Intramuscular Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Antares Pharma Company Detail
    Table 42. Antares Pharma Business Overview
    Table 43. Antares Pharma Intramuscular Drug Delivery Product
    Table 44. Antares Pharma Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
    Table 45. Antares Pharma Recent Development
    Table 46. Eli Lily Company Detail
    Table 47. Eli Lily Business Overview
    Table 48. Eli Lily Intramuscular Drug Delivery Product
    Table 49. Eli Lily Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
    Table 50. Eli Lily Recent Development
    Table 51. Galaxo Company Detail
    Table 52. Galaxo Business Overview
    Table 53. Galaxo Intramuscular Drug Delivery Product
    Table 54. Galaxo Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
    Table 55. Galaxo Recent Development
    Table 56. HMD pharmaceuticals Company Detail
    Table 57. HMD pharmaceuticals Business Overview
    Table 58. HMD pharmaceuticals Intramuscular Drug Delivery Product
    Table 59. HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
    Table 60. HMD pharmaceuticals Recent Development
    Table 61. Inovio Pharmaceuticals Company Detail
    Table 62. Inovio Pharmaceuticals Business Overview
    Table 63. Inovio Pharmaceuticals Intramuscular Drug Delivery Product
    Table 64. Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
    Table 65. Inovio Pharmaceuticals Recent Development
    Table 66. Merck Company Detail
    Table 67. Merck Business Overview
    Table 68. Merck Intramuscular Drug Delivery Product
    Table 69. Merck Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
    Table 70. Merck Recent Development
    Table 71. Novartis Company Detail
    Table 72. Novartis Business Overview
    Table 73. Novartis Intramuscular Drug Delivery Product
    Table 74. Novartis Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
    Table 75. Novartis Recent Development
    Table 76. Pacira Pharmaceuticals Company Detail
    Table 77. Pacira Pharmaceuticals Business Overview
    Table 78. Pacira Pharmaceuticals Intramuscular Drug Delivery Product
    Table 79. Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
    Table 80. Pacira Pharmaceuticals Recent Development
    Table 81. Pfizer Company Detail
    Table 82. Pfizer Business Overview
    Table 83. Pfizer Intramuscular Drug Delivery Product
    Table 84. Pfizer Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
    Table 85. Pfizer Recent Development
    Table 86. Pharmajet Company Detail
    Table 87. Pharmajet Business Overview
    Table 88. Pharmajet Intramuscular Drug Delivery Product
    Table 89. Pharmajet Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
    Table 90. Pharmajet Recent Development
    Table 91. Teva Pharmaceutical Company Detail
    Table 92. Teva Pharmaceutical Business Overview
    Table 93. Teva Pharmaceutical Intramuscular Drug DeliveryProduct
    Table 94. Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2017-2022) & (US$ Million)
    Table 95. Teva Pharmaceutical Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Intramuscular Drug Delivery Market Share by Type: 2021 VS 2028
    Figure 2. Drug Molecule Features
    Figure 3. Delivery Devices Features
    Figure 4. Global Intramuscular Drug Delivery Market Share by Application in 2021 & 2028
    Figure 5. Infectious Disease Case Studies
    Figure 6. Oncology Case Studies
    Figure 7. Autoimmune Diseases Case Studies
    Figure 8. Intramuscular Drug Delivery Report Years Considered
    Figure 9. Global Intramuscular Drug Delivery Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Intramuscular Drug Delivery Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Intramuscular Drug Delivery Market Share by Region: 2021 VS 2028
    Figure 12. Global Intramuscular Drug Delivery Market Share by Players in 2021
    Figure 13. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Drug Delivery as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Intramuscular Drug Delivery Revenue in 2021
    Figure 15. North America Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Intramuscular Drug Delivery Market Share by Country (2017-2028)
    Figure 17. United States Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Intramuscular Drug Delivery Market Share by Country (2017-2028)
    Figure 21. Germany Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Intramuscular Drug Delivery Market Share by Region (2017-2028)
    Figure 29. China Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Intramuscular Drug Delivery Market Share by Country (2017-2028)
    Figure 37. Mexico Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Intramuscular Drug Delivery Market Share by Country (2017-2028)
    Figure 41. Turkey Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Intramuscular Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Antares Pharma Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
    Figure 44. Eli Lily Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
    Figure 45. Galaxo Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
    Figure 46. HMD pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
    Figure 47. Inovio Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
    Figure 48. Merck Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
    Figure 49. Novartis Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
    Figure 50. Pacira Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
    Figure 51. Pfizer Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
    Figure 52. Pharmajet Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
    Figure 53. Teva Pharmaceutical Revenue Growth Rate in Intramuscular Drug Delivery Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Antares Pharma
Eli Lily
Galaxo
HMD pharmaceuticals
Inovio Pharmaceuticals
Merck
Novartis
Pacira Pharmaceuticals
Pfizer
Pharmajet
Teva Pharmaceutical
Frequently Asked Questions
Intramuscular Drug Delivery report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Intramuscular Drug Delivery report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Intramuscular Drug Delivery report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports